feature image

Institutional Biosafety Committee

The Institutional Biosafety Committee is responsible for monitoring and ensuring compliance as well as review and approval of all research projects that involve recombinant or synthetic nucleic acid molecules, including human gene transfer (clinical trials) in accordance with the NIH Guidelines.


 IMPORTANT DEADLINE:  June 30, 2016  

Legacy Applications (Paper) will no longer be accepted by the IBC Office for New or Full Renewal protocols on July 1, 2016

The IBC will use MyIBC on-line application processing system for review 

Essential Step:

 Click here for paper application (The paper application is invalid for use on July 1, 2016)

 Research Guidance Tool>>

page updated 2 June 2016